> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Will Allow Some Omega-3 Health Claims
- URL: https://www.fdaweb.com/fda-will-allow-some-omega-3-health-claims/
- Published: 2019-06-19T12:00:00.000Z
- Updated: 2026-09-15T01:33:41.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144375

FDA says it will not object to use of certain qualified health claims that consuming eicosapentaenoic acid (EPA) and docosahexaenoic (DHA) omega-3 fatty acids in food or dietary supplements may reduce the risk of hypertension and coronary heart disease. The statement came in an agency [response](https://www.fda.gov/media/128043/download?utm%5Fcampaign=CFSANCU%20-%20FDA%20Announces%20New%20Qualified%20Health%20Claims%20for%20EPA%20and%20DHA%20Omega-3&utm%5Fmedium=email&utm%5Fsource=Eloqua) to a 4/24/14 petition from the Global Organization for EPA and DHA Omega-3s. The response says the agency will use enforcement discretion to not object to claims that are consistent with factors described in the letter.

FDA says it determined that the overall evidence did not meet the “significant scientific agreement” standard required for an authorized health claim, but did meet the “credible evidence” standard for a qualified health claim in the labeling of conventional foods and dietary supplements.

While there is some credible evidence suggesting that combined intake of EPA and DHA from conventional foods and dietary supplements may reduce the risk of hypertension by lowering blood pressure, FDA says, the evidence is highly inconclusive and highly inconsistent.